Segment Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $791K | Sell |
1,578
-325
| -17% | -$156K | 0.04% | 191 |
|
|
2026
Q1 | $935K | Buy |
1,903
+315
| +20% | +$171K | 0.05% | 172 |
|
|
2025
Q4 | $920K | Buy |
1,588
+135
| +9% | +$76.3K | 0.05% | 176 |
|
|
2025
Q3 | $705K | Sell |
1,453
-106
| -7% | -$49.3K | 0.04% | 188 |
|
|
2025
Q2 | $632K | Sell |
1,559
-141
| -8% | -$59K | 0.04% | 187 |
|
|
2025
Q1 | $846K | Sell |
1,700
-129
| -7% | -$69.9K | 0.06% | 163 |
|
|
2024
Q4 | $952K | Sell |
1,829
-4,100
| -69% | -$2.25M | 0.06% | 153 |
|
|
2024
Q3 | $3.67M | Buy |
5,929
+116
| +2% | +$68.7K | 0.25% | 75 |
|
|
2024
Q2 | $3.21M | Buy |
5,813
+471
| +9% | +$270K | 0.24% | 78 |
|
|
2024
Q1 | $3.1M | Buy |
5,342
+964
| +22% | +$541K | 0.24% | 82 |
|
|
2023
Q4 | $2.32M | Sell |
4,378
-406
| -8% | -$197K | 0.21% | 85 |
|
|
2023
Q3 | $2.42M | Buy |
4,784
+583
| +14% | +$311K | 0.25% | 80 |
|
|
2023
Q2 | $2.19M | Sell |
4,201
-78
| -2% | -$42.1K | 0.23% | 84 |
|
|
2023
Q1 | $2.47M | Sell |
4,279
-22
| -0.5% | -$12.4K | 0.28% | 75 |
|
|
2022
Q4 | $2.37M | Sell |
4,301
-92
| -2% | -$48.7K | 0.27% | 78 |
|
|
2022
Q3 | $2.23M | Buy |
4,393
+129
| +3% | +$72.2K | 0.28% | 79 |
|
|
2022
Q2 | $2.32M | Sell |
4,264
-422
| -9% | -$232K | 0.29% | 73 |
|
|
2022
Q1 | $2.77M | Buy |
4,686
+68
| +1% | +$39.1K | 0.29% | 79 |
|
|
2021
Q4 | $3.08M | Buy |
4,618
+332
| +8% | +$207K | 0.32% | 75 |
|
|
2021
Q3 | $2.45M | Buy |
4,286
+2
| +0% | +$1.1K | 0.29% | 82 |
|
|
2021
Q2 | $2.16M | Sell |
4,284
-1
| -0% | -$472 | 0.26% | 89 |
|
|
2021
Q1 | $1.96M | Buy |
4,285
+223
| +5% | +$106K | 0.26% | 88 |
|
|
2020
Q4 | $1.89M | Buy |
4,062
+1,603
| +65% | +$752K | 0.27% | 84 |
|
|
2020
Q3 | $1.09M | Buy |
2,459
+859
| +54% | +$355K | 0.18% | 98 |
|
|
2020
Q2 | $580K | Sell |
1,600
-100
| -6% | -$33.5K | 0.11% | 120 |
|
|
2020
Q1 | $482K | Buy |
1,700
+610
| +56% | +$192K | 0.11% | 120 |
|
|
2019
Q4 | $354K | Buy |
1,090
+18
| +2% | +$5.46K | 0.06% | 177 |
|
|
2019
Q3 | $312K | Hold |
1,072
| – | – | 0.06% | 164 |
|
|
2019
Q2 | $315K | Hold |
1,072
| – | – | 0.06% | 154 |
|
|
2019
Q1 | $293K | Sell |
1,072
-113
| -10% | -$28.1K | 0.06% | 162 |
|
|
2018
Q4 | $265K | Sell |
1,185
-118
| -9% | -$27.7K | 0.07% | 150 |
|
|
2018
Q3 | $318K | Buy |
+1,303
| New | +$300K | 0.07% | 160 |
|
Other funds holding TMO
Segment Wealth Management's TMO Position: Q2 2026 in Review
Segment Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $156K and leaving 1,578 shares worth $791K. The position accounts for 0.04% of the portfolio, ranked #191.
Segment Wealth Management first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $3.67M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Segment Wealth Management held 1,578 shares of Thermo Fisher Scientific worth $791K as of Q2 2026.
- Segment Wealth Management sold 325 Thermo Fisher Scientific shares in Q2 2026, an estimated $156K.
- Thermo Fisher Scientific made up 0.04% of Segment Wealth Management's portfolio in Q2 2026, its #191 holding.
- Segment Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- Segment Wealth Management's Thermo Fisher Scientific position peaked at $3.67M in Q3 2024.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Segment Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.